Full Text View
Tabular View
No Study Results Posted
Related Studies
Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®
This study has been completed.
Study NCT00475553   Information provided by Scott and White Hospital & Clinic

First Received on May 16, 2007.   Last Updated on December 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breakthrough Bleeding
Breakthrough Spotting
Additional conditions recognized in this trial
Hemorrhage
Metrorrhagia
More general conditions related to this trial
Genital Diseases, Female
Pathologic Processes
Uterine Diseases
Uterine Hemorrhage
Interventions listed in this trial
If bleeding does not remove ring
Additional drug interventions recognized in this trial
3-keto-desogestrel
Estradiol
Ethinyl Estradiol
More general drug interventions related to this trial
Contraceptive Agents
Contraceptive Agents, Female
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Scott and White Hospital & Clinic
Organon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services